Dexcom (DXCM) Change in Receivables (2010 - 2026)

Dexcom (DXCM) has 17 years of Change in Receivables data on file, last reported at -$124.6 million in Q1 2026.

• On a quarterly basis, Change in Receivables fell 183.68% year-over-year to -$124.6 million in Q1 2026; TTM through Mar 2026 was -$71.6 million, a 140.2% decrease from a year earlier, with the FY2025 full-year figure at $201.9 million, up 476.86% from the prior year.
• Change in Receivables for Q1 2026 stood at -$124.6 million, down from $106.2 million in the prior quarter.
• Over the last five years, Change in Receivables for DXCM reached as high as $187.2 million in Q4 2023 and fell as low as -$237.8 million in Q3 2025.
• Historically, Change in Receivables has averaged $33.7 million across 5 years, with a median of $30.1 million in 2022.
• On a YoY basis, Change in Receivables climbed as much as 2467.24% in 2025 and fell as far as 527.7% in 2025.
• Year by year, Change in Receivables stood at $148.3 million in 2022, then gained by 26.23% to $187.2 million in 2023, then slumped by 96.05% to $7.4 million in 2024, then soared by 1335.14% to $106.2 million in 2025, then sank by 217.33% to -$124.6 million in 2026.
• Per Business Quant data, the three most recent Change in Receivables figures were -$124.6 million in Q1 2026, $106.2 million in Q4 2025, and -$237.8 million in Q3 2025.